Author

Lillian Reich

Observed names: L Reich, L. Reich, Lillian M Reich

Institution: Memorial Sloan Kettering Cancer Center

Observed institutions: Memorial Sloan Kettering Cancer Center, Cornell University, Weill Cornell Medicine

OpenAlex ID: A5113693229

Transfusion-Associated Acute Chagas Disease Acquired in the United States

1989 · Irene H. Grant, Jonathan W.M. Gold, et al. · Annals of Internal Medicine · 228

Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes

1990 · Henry F. Furneaux, Lillian Reich, et al. · Neurology · 212

Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin Plus Etoposide in Previously Treated Germ Cell Tumors

2006 · G. Varuni Kondagunta, Jennifer Bacik, et al. · Journal of Clinical Oncology · 138

Combination chemotherapy of advanced chronic lymphocytic leukemia: the M-2 protocol (vincristine, BCNU, cyclophosphamide, melphalan, and prednisone).

1982 · S Kempin, B J Lee, et al. · PubMed · 88

Optimization of conditions for ex vivo expansion of CD34+ cells from patients with stage IV breast cancer

1994 · F Shapiro, TJ Yao, et al. · Blood · 70

Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocol.

1989 · E Berman, Z A Arlin, et al. · PubMed · 50

Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer.

1998 · C Aghajanian, D Fennelly, et al. · Journal of Clinical Oncology · 44

Simultaneous dose escalation and schedule intensification of carboplatin-based chemotherapy using peripheral blood progenitor cells and filgrastim: a phase I trial.

1994 · D Fennelly, C Wasserheit, et al. · PubMed · 18

Rapidly cycled courses of high-dose alkylating agents supported by filgrastim and peripheral blood progenitor cells in patients with metastatic breast cancer.

1995 · L Vahdat, G Raptis, et al. · PubMed · 16

Immune-mediated thrombocytopenia secondary to suramin

1993 · Andrew D. Seidman, Michael Schwartz, et al. · Cancer · 15

Effects of prior therapy on the in vitro proliferative potential of stem cell factor plus filgrastim-mobilized CD34-positive progenitor cells.

1997 · F Shapiro, T J Yao, et al. · PubMed · 12

Acute renal failure associated with the retinoic acid syndrome in acute promyelocytic leukemia

1996 · Carlos D. Flombaum, Marian Isaacs, et al. · American Journal of Kidney Diseases · 11

Adjuvant Dexamethasone (D) ± Thalidomide (T) Improves Hematologic and Organ Responses after Risk-Adapted High-Dose Melphalan with Autologous Stem Cell Transplant (SCT) for Patients with Systemic AL Amyloidosis (AL).

2005 · Adam D. Cohen, Ping Zhou, et al. · Blood · 6

Sequential dose-intensive paclitaxel plus ifosfamide and carboplatin plus etoposide with autologous stem cell transplantation for germ cell tumor (GCT) patients (pts)

2005 · G. V. Kondagunta, J. Bacik, et al. · Journal of Clinical Oncology · 5

Sequential Administration of Bortezomib, Liposomal Doxorubicin and Dexamethasone (BDD) Followed by Thalidomide and Dexamethasone (TD) Results in Rapid Control of Untreated High-Risk Multiple Myeloma (MM) and Improves Depth of Response

2008 · Heather Landau, Hani Hassoun, et al. · Blood · 2

Risk-Adapted Intravenous Melphalan Followed by Adjuvant Dexamethasone (D) and Thalidomide (T) for Newly Diagnosed Patients with Systemic AL Amyloidosis (AL): Interim Results of a Phase II Study.

2004 · Adam D. Cohen, Ping Zhou, et al. · Blood · 2

Abuse of Coronary Arteriography

1980 · E A Phillips, S Kempin, et al. · New England Journal of Medicine · 1

Feasibility of Collecting Peripheral Blood Stem Cells (pbsc) in an Ambulatory Facility From Children Weighing < 25 Kg. 915

1996 · Sharon L Gardner, Eileen M Walsh, et al. · Pediatric Research

Works count: 18

Citation count: 918

H-index: 11

I10-index: 12